首页 | 本学科首页   官方微博 | 高级检索  
检索        

不对称氢化、氢转移反应制备(R)-邻氯扁桃酸甲酯:(S)-氯吡格雷关键中间体的不对称合成
引用本文:尹 璐,贾 娴,黎星术.不对称氢化、氢转移反应制备(R)-邻氯扁桃酸甲酯:(S)-氯吡格雷关键中间体的不对称合成[J].中国药物化学杂志,2009,19(6):416-419.
作者姓名:尹 璐  贾 娴  黎星术
作者单位:(1. 沈阳药科大学 制药工程学院,辽宁 沈阳 110016; ;2. 中山大学 药学院,广东 广州 510080)
摘    要:目的 用不对称氢化、氢转移方法制备合成(S)-氯吡格雷的关键中间体——(R)-邻氯扁桃酸甲酯。方法 以α-邻氯扁桃酮酸甲酯为起始原料,分别用不对称氢化和氢转移方法制备(R)-邻氯扁桃酸甲酯。结果与结论 使用不对称氢化方法制备(R)-邻氯扁桃酸甲酯,对映选择性为64.8% ,用氢转移方法,优化催化条件后目标产物的ee值高达92.6%,从而为(S)-氯吡格雷的不对称合成奠定了基础。

关 键 词:不对称氢化反应  氢转移反应  (R)-邻氯扁桃酸甲酯  (S)-氯吡格雷
收稿时间:2009-8-19
修稿时间:2009-10-10

Preparation of methyl (R)-o-chloromandelate by asymmetric hydrogenation and transfer hydrogenation: enantioselective synthesis of the key intermediate for (S)-clopidogrel
YIN Lu,JIA Xian,LI Xing-shu.Preparation of methyl (R)-o-chloromandelate by asymmetric hydrogenation and transfer hydrogenation: enantioselective synthesis of the key intermediate for (S)-clopidogrel[J].Chinese Journal of Medicinal Chemistry,2009,19(6):416-419.
Authors:YIN Lu  JIA Xian  LI Xing-shu
Institution:(1. School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China; 2. School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510080, China)
Abstract:Aim To prepare methyl (R)-o-chloromandelate (key intermediate for (S)-clopidogrel) by asymmetric hydrogenation and transfer hydrogenation. Methods methyl (R)-o-chloromandelate was prepared by asymmetric hydrogenation and asymmetric transfer hydrogenation from methyl o-chlorobenzoylformate. Results and conclusion 64.8% ee was achieved for methyl (R)-o-chloromandelate by asymmetric hydrogenation, while enantioselectivity was up to 92.6% ee for the key intermediate for (S)-clopidogrel under an optimal condition by asymmetric transfer hydrogenation.
Keywords:asymmetric hydrogenation  transfer hydrogenation  methyl (R)-o-chloromandelate  (S)-clopidogrel
点击此处可从《中国药物化学杂志》浏览原始摘要信息
点击此处可从《中国药物化学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号